Senior Consultant, Clinical Hematology
Department
Department of Clinical Hematology
09810709038
Dr. Pallavi Mehta is an experienced Clinical Haematologist with expertise in managing a wide range of benign and malignant blood disorders in both adult and paediatric patients. She holds an M.B.B.S. from Pt. B.D. Sharma University, Rohtak, an M.D. in Medicine from the Post Graduate Institute of Medical Sciences, Rohtak, and a D.M. in Clinical Haematology from Christian Medical College, Vellore. With extensive clinical experience across leading hospitals, she specialises in the management of blood cancers, thalassemia, sickle cell disease, aplastic anaemia and other complex haematological conditions.
Dr. Pallavi Mehta has significant expertise in haematopoietic stem cell transplantation, including autologous, allogeneic and haploidentical transplants, as well as CAR-T and other cell-based therapies. She has been actively involved in paediatric stem cell transplantation for thalassemia and other blood disorders and has contributed to research in stem cell transplantation, gene editing and advanced haematological treatments. Her work has been published in several peer-reviewed medical journals, and she has presented research at international conferences, reflecting her commitment to advancing haematology and providing comprehensive, evidence-based patient care.
Kapoor J, Mirgh SP, Khushoo V, Mehta P, Ahmed R, Bansal N, Bhurani D, Agrawal N. Study of clinical characteristics, risk factors and outcomes for tuberculosis post allogeneic stem cell transplant: never count it out. Ther Adv Infect Dis. 2021.Apr12;8.
Dinesh Bhurani, Jyotsna Kapoor, Neha Yadav, Vishvdeep Khushoo, Narendra Agrawal, Rayaz Ahmed, Jatinder Singh Arora, Pallavi Mehta. Experience with low dose thalidomide in transfusion dependent beta thalassemia patients. Ann Hematol. 2021 Jun;100(6):1417-1427.
Pallavi Mehta, Stalin Ramprakash, C P Raghuram, Deepa Trivedi, Rakesh Dhanya, Rajat Kumar Agarwal, Lawrence Faulkner. Pre-transplant Donor-Type Red Cell Transfusion is safe and effective strategy to reduce isohaemagglutinin titers and prevent donor marrow infusion reactions in major ABO mismatched transplants. Ann Hematol. 2021 Aug;100(8):2071-2078.
Pallavi Mehta, Neha Yadav, Bhaarat Folbs, Jyotsna Kapoor, Vishuvdeep Khushoo, Narender Agrawal, Rayaz Ahmed, Dinesh Bhurani. Retrospective study of Carfilzomib-Pomalidomide-Dexamethasone in Relapsed/Refractory Multiple Myeloma patients in a tertiary care hospital in India. Indian J Hematol Blood Transfus (2021).
Jyotsna Kapoor, Sumeet Prakash Mirgh, Narendra Aggrawal, Vishuvdeep Khushoo, Narender Tejwani, Reema Singh, Pallavi Mehta, Dinesh Bhurani, Rayaz Ahmed. High risk Acute Promyelocytic Leukemia- AN Enigma for Hematologists: Optimizing Treatment with APML-4 Protocol. Indian J Hematol Blood Transfus published on 3.9.2021.
Pallavi Mehta, Jyotsna Kapoor, Nitin Bansal, Akansha Singh, Narender Agrawal, Rayaz Ahmed, Dinesh Bhurani. Evan’s in a case of Acute Myeloid Leukemia post COVID-19 infection. Clinics in Oncology Research. July 2021. Doi:10.26420/clinoncolres.2021.1010
Pallavi Mehta, Akansha Singh, Rohan Halder, Ankit Garg, Narender Agrawal, Rayaz Ahmed, Dinesh Bhurani. Hemophagocytic Lymphohistiocytosis (HLH): A rare cause of primary engraftment failure post autologous stem cell transplant. Accepted for publication in South Asian Journal of Cancer on 5th March, 2022.
Mehta P, Kapoor J, Singh A, Yadav N, Singh R, Halder R, Verma M, Agrawal N, Ahmed R, Bhurani D. Busulfan and cyclophosphamide-based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion-dependent thalassemia, even in high risk. Eur J Haematol. 2022 Nov;109(5):447-457.
Pallavi Mehta, Narendra Agrawal, Rayaz Ahmed, Dinesh Bhurani. Immunosuppression boost, in contrast to conventional approach of immunosuppression tapering, in patients with mixed chimerism in thalassemia post stem cell transplant. Transplantation and Cellular Therapy, Nov, 2022.
Sujay Rainchwar, Rohan Halder, Reema Singh, Pallavi Mehta, Megha Verma, Narendra Agrawal, Rayaz Ahmed, Dinesh Bhurani, Nitin Bansal. Pneumocystis jirovecii pneumonia [PJP]: An unrecognized concern in AML patients on Venetoclax. Leukemia Research, Volume 121,2022.
Pallavi Mehta, Khushoo V. Is Old (Fludrabine/Busulfan/Cyclophosphamide/rAntiThymocyteGlobulin) Conditioning Still Gold for Allogeneic Transplants in Transfusion Dependent Beta-Thalassemia of All Risk Categories in 21st Century?. Indian J Hematol Blood Transfus (2023).
Pallavi Mehta, Vishuvdeep Khushoo. Haploidentical stem cell transplantation for hematological disorders: Real world experience from India. South Asian journal of Cancer, September 2023, doi: 10.1055/s-0043-1771274
Mehta Pallavi & Raut Santosh & Rastogi Neha & Kumar Meet & Dua Vikas & Bhargava Rahul. (2023). Daratumumab for De-sensitization of Donor Specific Antibodies: Is it a Quicker and Easier way? Indian Journal of Hematology and Blood Transfusion. 10.1007/s12288-023-01712-8.
Pallavi Mehta. Time for newer approach in age-old AIHA. The Lancet Regional Health - Southeast Asia 2024;23: 100378. https://doi.org/10. 1016/j.lansea.2024. 100378
Chatterjee Tathagat and Bhargava Rahul and More Shilpi and Mehta Pallavi, Rai Sanjay, Pandey Anil Kumar and Rajput Saroj and Sharma Nimisha and Sharma Geetika and Taneja Juhi, Chaudhary Sonu, Kashyap Sanchi and Singh Sandeep Kumar. Haematopoietic Stem Cell Transplantation in a Government Setup in India: New Directions in Indian Healthcare; Way to Go! Available at SSRN: https://ssrn.com/abstract=4676967 or http://dx.doi.org/10.2139/ssrn.4676967( Preprints with The Lancet)
Md Masoom, Haya Majid, Pallavi Mehta, Narendra Agrawal, Rayaz Ahmed, Dinesh Bhurani, Mohd Ashif Khan. Retrospective study to compare the outcomes of matched related donor vs matched unrelated donor in patient with acute myeloid leukaemia. Clinical Epidemiology and Global Health 28 (2024) 101648.
Pallavi Mehta. Daratumumumab induces rapid and sustained responses in immune cytopenia: A case series. Indian Journal of Haematology and Blood Tranfusion (2025). https://doi.org/10.1007/s12288-025-02158-w.
Sangam Giri Goswami, Pragya Gupta, Arvinden V R, Nupur Bhargava, Vinodh Saravanakumar, Aditya Ramdas Iyer, Somesh K. Jha, Shivani Singh, Ajay Kumar, Praveen Singh, Padma Gunda, Suman Jain, Pallavi Mehta, Yukio Nakamura, Ryo Kurita, Avinash Bajaj, Sivaprakash Ramalingam. CRISPR editing of HPFH3 genotype induces gamma-globulin expression and reverses sickle cell disease and beta thalassemia phenotype. Accepted in Journal Stem Cell Research and Therapy.
Pallavi Mehta. Letter to the Editor: A rare severe hemolytic crisis in the Homozygous Hemoglobin E (HbEE) state. Accepted in Hemoglobin in Nov 2025.. Article ID: IHEM 2580388. doi: 10.1080/03630269.2025.2580388.
Setting up and Sustaining Blood and Marrow Transplant Services for Children in Middle-Income Economies: An Experience-Driven Position Paper on Behalf of the EBMT PDWP. Journal: Bone Marrow Transplantation, 2020.

